BioNTech SE Sponsored ADR (BNTX) vs Incyte Corporation (INCY)
BioNTech SE Sponsored ADR and Incyte Corporation are both Biotechnology companies. BioNTech SE Sponsored ADR and Incyte Corporation are of similar size ($25.5B and $24.9B). BioNTech SE Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Incyte Corporation trades at 15.2×. Incyte Corporation grew revenue faster over the last twelve months: 26.9% against −3.33%. Incyte Corporation has the higher net margin (27.7% vs −65.8%) and the higher return on invested capital (60.5% vs −38.4%). Across the 19 metrics below, Incyte Corporation leads on 15 and BioNTech SE Sponsored ADR on 4.
Valuation
Profitability
| Metric | BNTX | INCY | Biotechnology median |
|---|---|---|---|
| Gross margin | 75.24% | 92.62% | 65.16% |
| Operating margin | (77.94%) | 30.56% | 0.00% |
| Net margin | (65.75%) | 27.71% | 0.00% |
| Free cash flow margin | 16.58% | 32.48% | 0.00% |
| Return on equity | (9.53%) | 30.67% | (57.72%) |
| Return on assets | (8.24%) | 23.55% | (49.22%) |
| Return on invested capital | (38.39%) | 60.50% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack